Kimberly Witzmann from the Office of Bioequivalence in CDER’s Office of Generic Drugs discusses generic drug product substitutability and the draft comparative analyses guidance.

Learn more at [ Ссылка ]


_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Visit [ Ссылка ] and [ Ссылка ] for news and a repository of training activities.

Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
CDER small business e-mail update subscription: [ Ссылка ]

свернуть